It is noteworthy to mention 51% of prostate tumors (20 of 39) and 25% of tumors (10 of 39) had 5 fold higher gp78 mRNA expression and Hrd1 mRNA expression, respectively, compared to normal prostate tissue controls (n = 9) (Table 1). The gene discussed is SYVN1; the disease is prostate neoplasm.